STIFEL FINANCIAL CORP
Position in PACB — Pacific Biosciences Of California, Inc.
CIK 720672
ST. LOUIS, MO
Position in PACB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$114,658
+$22,225 QoQ
Shares Held
68,249
-2.5% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 222 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PACB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $1,174,195,225 across 37 Medical Devices names. PACB ranks #35 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
6,064,377 | $474,416,209 | |
| 2 | ABT |
Abbott Laboratories
|
3,797,845 | $344,616,452 | |
| 3 | SYK |
Stryker Corp
|
568,038 | $178,841,081 | |
| 4 | BSX |
Boston Scientific Corp
|
1,760,990 | $75,159,051 | |
| 5 | EW |
Edwards Lifesciences Corp
|
212,736 | $19,244,096 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
215,446 | $13,790,697 | |
| 7 | STE |
STERIS plc
|
53,511 | $11,267,811 | |
| 8 | GMED |
Globus Medical Inc
|
111,925 | $8,843,192 |
All Filings in PACB
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $114,658 | 68,249 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $92,433 | 70,026 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $132,507 | 70,860 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $70,027 | 54,709 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $70,818 | 57,112 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $70,247 | 59,532 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $123,580 | 67,531 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $86,168 | 50,688 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $61,044 | 44,559 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $210,277 | 56,074 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,313,303 | 133,874 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $804,254 | 96,318 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,131,816 | 85,099 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $995,450 | 85,963 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $839,660 | 102,648 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $627,851 | 108,064 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $432,071 | 97,754 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $824,177 | 90,569 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,335,076 | 65,253 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,264,446 | 127,767 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,508,577 | 128,927 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,631,589 | 109,024 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $925,565 | 35,681 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||